List of Tables
Table 1. Age-related Macular Degeneration Market Trends
Table 2. Age-related Macular Degeneration Market Drivers & Opportunity
Table 3. Age-related Macular Degeneration Market Challenges
Table 4. Age-related Macular Degeneration Market Restraints
Table 5. Global Age-related Macular Degeneration Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Age-related Macular Degeneration Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Age-related Macular Degeneration Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Age-related Macular Degeneration Product Type
Table 9. Key Companies Time to Begin Mass Production of Age-related Macular Degeneration
Table 10. Global Age-related Macular Degeneration Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Age-related Macular Degeneration Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Age-related Macular Degeneration Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Age-related Macular Degeneration Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Age-related Macular Degeneration Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Age-related Macular Degeneration Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Age-related Macular Degeneration Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Age-related Macular Degeneration Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Age-related Macular Degeneration Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Age-related Macular Degeneration Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Age-related Macular Degeneration Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Age-related Macular Degeneration Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Age-related Macular Degeneration Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Age-related Macular Degeneration Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Age-related Macular Degeneration Sales Value by Region (2019-2024) & (%)
Table 27. Global Age-related Macular Degeneration Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Age-related Macular Degeneration Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Age-related Macular Degeneration Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Age-related Macular Degeneration Sales Value, (2025-2030) & (US$ Million)
Table 31. Bayer HealthCare Basic Information List
Table 32. Bayer HealthCare Description and Business Overview
Table 33. Bayer HealthCare Age-related Macular Degeneration Products, Services and Solutions
Table 34. Revenue (US$ Million) in Age-related Macular Degeneration Business of Bayer HealthCare (2019-2024)
Table 35. Bayer HealthCare Recent Developments
Table 36. F. Hoffmann-La Roche Basic Information List
Table 37. F. Hoffmann-La Roche Description and Business Overview
Table 38. F. Hoffmann-La Roche Age-related Macular Degeneration Products, Services and Solutions
Table 39. Revenue (US$ Million) in Age-related Macular Degeneration Business of F. Hoffmann-La Roche (2019-2024)
Table 40. F. Hoffmann-La Roche Recent Developments
Table 41. Novartis Basic Information List
Table 42. Novartis Description and Business Overview
Table 43. Novartis Age-related Macular Degeneration Products, Services and Solutions
Table 44. Revenue (US$ Million) in Age-related Macular Degeneration Business of Novartis (2019-2024)
Table 45. Novartis Recent Developments
Table 46. Regeneron Pharmaceuticals Basic Information List
Table 47. Regeneron Pharmaceuticals Description and Business Overview
Table 48. Regeneron Pharmaceuticals Age-related Macular Degeneration Products, Services and Solutions
Table 49. Revenue (US$ Million) in Age-related Macular Degeneration Business of Regeneron Pharmaceuticals (2019-2024)
Table 50. Regeneron Pharmaceuticals Recent Developments
Table 51. Alcon Basic Information List
Table 52. Alcon Description and Business Overview
Table 53. Alcon Age-related Macular Degeneration Products, Services and Solutions
Table 54. Revenue (US$ Million) in Age-related Macular Degeneration Business of Alcon (2019-2024)
Table 55. Alcon Recent Developments
Table 56. Allergan Basic Information List
Table 57. Allergan Description and Business Overview
Table 58. Allergan Age-related Macular Degeneration Products, Services and Solutions
Table 59. Revenue (US$ Million) in Age-related Macular Degeneration Business of Allergan (2019-2024)
Table 60. Allergan Recent Developments
Table 61. Avalanche Basic Information List
Table 62. Avalanche Description and Business Overview
Table 63. Avalanche Age-related Macular Degeneration Products, Services and Solutions
Table 64. Revenue (US$ Million) in Age-related Macular Degeneration Business of Avalanche (2019-2024)
Table 65. Avalanche Recent Developments
Table 66. Bausch+Lomb Basic Information List
Table 67. Bausch+Lomb Description and Business Overview
Table 68. Bausch+Lomb Age-related Macular Degeneration Products, Services and Solutions
Table 69. Revenue (US$ Million) in Age-related Macular Degeneration Business of Bausch+Lomb (2019-2024)
Table 70. Bausch+Lomb Recent Developments
Table 71. Gilead Sciences Basic Information List
Table 72. Gilead Sciences Description and Business Overview
Table 73. Gilead Sciences Age-related Macular Degeneration Products, Services and Solutions
Table 74. Revenue (US$ Million) in Age-related Macular Degeneration Business of Gilead Sciences (2019-2024)
Table 75. Gilead Sciences Recent Developments
Table 76. Iconic Therapeutics Basic Information List
Table 77. Iconic Therapeutics Description and Business Overview
Table 78. Iconic Therapeutics Age-related Macular Degeneration Products, Services and Solutions
Table 79. Revenue (US$ Million) in Age-related Macular Degeneration Business of Iconic Therapeutics (2019-2024)
Table 80. Iconic Therapeutics Recent Developments
Table 81. Neurotech Pharmaceuticals Basic Information List
Table 82. Neurotech Pharmaceuticals Description and Business Overview
Table 83. Neurotech Pharmaceuticals Age-related Macular Degeneration Products, Services and Solutions
Table 84. Revenue (US$ Million) in Age-related Macular Degeneration Business of Neurotech Pharmaceuticals (2019-2024)
Table 85. Neurotech Pharmaceuticals Recent Developments
Table 86. Ohr Pharmaceutical Basic Information List
Table 87. Ohr Pharmaceutical Description and Business Overview
Table 88. Ohr Pharmaceutical Age-related Macular Degeneration Products, Services and Solutions
Table 89. Revenue (US$ Million) in Age-related Macular Degeneration Business of Ohr Pharmaceutical (2019-2024)
Table 90. Ohr Pharmaceutical Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Age-related Macular Degeneration Downstream Customers
Table 94. Age-related Macular Degeneration Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Age-related Macular Degeneration Product Picture
Figure 2. Global Age-related Macular Degeneration Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Age-related Macular Degeneration Sales Value (2019-2030) & (US$ Million)
Figure 4. Age-related Macular Degeneration Report Years Considered
Figure 5. Global Age-related Macular Degeneration Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Age-related Macular Degeneration Revenue in 2023
Figure 7. Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Wet AMD Picture
Figure 9. Dry AMD Picture
Figure 10. Global Age-related Macular Degeneration Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Age-related Macular Degeneration Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Drugstore
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Others
Figure 15. Global Age-related Macular Degeneration Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Age-related Macular Degeneration Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Age-related Macular Degeneration Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Age-related Macular Degeneration Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Age-related Macular Degeneration Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Age-related Macular Degeneration Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Age-related Macular Degeneration Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Age-related Macular Degeneration Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Age-related Macular Degeneration Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Age-related Macular Degeneration Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Age-related Macular Degeneration Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Age-related Macular Degeneration Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Age-related Macular Degeneration Sales Value (%), (2019-2030)
Figure 28. United States Age-related Macular Degeneration Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Age-related Macular Degeneration Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Age-related Macular Degeneration Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Age-related Macular Degeneration Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Age-related Macular Degeneration Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Age-related Macular Degeneration Sales Value by Application (%), 2023 VS 2030
Figure 34. China Age-related Macular Degeneration Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Age-related Macular Degeneration Sales Value by Type (%), 2023 VS 2030
Figure 36. China Age-related Macular Degeneration Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Age-related Macular Degeneration Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Age-related Macular Degeneration Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Age-related Macular Degeneration Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Age-related Macular Degeneration Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Age-related Macular Degeneration Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Age-related Macular Degeneration Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Age-related Macular Degeneration Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Age-related Macular Degeneration Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Age-related Macular Degeneration Sales Value by Application (%), 2023 VS 2030
Figure 46. India Age-related Macular Degeneration Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Age-related Macular Degeneration Sales Value by Type (%), 2023 VS 2030
Figure 48. India Age-related Macular Degeneration Sales Value by Application (%), 2023 VS 2030
Figure 49. Age-related Macular Degeneration Industrial Chain
Figure 50. Age-related Macular Degeneration Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation